Sofie de Jong

Sofie de Jong is an active medical researcher specializing in transplantation immunology and gastroenterology, contributing to high-impact studies through collaborations like the TransplantLines Investigators group. Her work focuses on molecular mechanisms in intestinal grafts and inflammatory bowel diseases.

Her research interests bridge clinical transplantation and molecular pathology, with emphasis on cellular signatures in small intestinal grafts, posttransplant recovery pathways, and disease phenotyping in PSC-IBD overlap syndromes. Key methodologies include molecular profiling of recipient-donor cell interactions and biomarker discovery for graft rejection.

Analysis of her publications reveals consistent focus on transplantation biomarkers (2024-2025) and foundational work in colorectal cancer apoptosis pathways (2004). Recent studies employ cellular signature mapping to differentiate successful versus rejected grafts, while earlier research explored TRAIL receptor dynamics in tumor evasion.

No scientific awards are documented in available sources.

Dr. de Jong participates in multi-institutional research teams including TransplantLines Investigators and collaborators from MedRxiv-published studies, though specific advising roles or grant details remain unreported. Current work suggests involvement in prospective graft monitoring protocols.

Her fingerprint indicates leadership in pretransplant molecular signature development and intestinal graft cellular profiling, with emerging work on DUOX2 expression in colitis variants.